• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Research and Markets: Key Pharmaceutical Subsidiaries Can Be Seen Inside the Dainippon Pharmaceutical Company Intelligence Report

Posted on: Thursday, 25 May 2006, 09:01 CDT

Research and Markets (http://www.researchandmarkets.com/reports/c37571) has announced the addition of Dainippon Pharmaceutical Company Intelligence Report from Espicom Business Intelligence to their offering.

Pharmaceutical company intelligence reports provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance is covered in-depth, from its latest results to a complete analysis of its latest full fiscal year and an outlook for the future. A section on company strategy covers mergers, acquisitions and divestitures, key agreements, products and R&D. An overview of key products and R&D is followed by a comprehensive review of the company's product portfolio and research and development pipeline by therapeutic area. In addition, supplementary appendices provide more in-depth information on financials, agreements and corporate events.

Contents are as follows:-

-- Executive Summary

-- Product Portfolio/Research & Development

-- Appendix 1 - Financial Performance

-- Appendix 2 - Key Agreements

-- Appendix 3 - Infrastructure

-- Appendix 4 - Key Pharmaceutical Subsidiaries/Joint Ventures

-- Appendix 5 - Product Index

-- Index of Tables

-- Index of Charts

Companies Mentioned Include:

-- Almirall Prodesfarma SA

-- Astellas Pharma

-- AstraZeneca

-- Conforma Therapeutics Corporation

-- Eisai

-- Gilead Sciences

-- Idenix Pharmaceuticals Inc

-- Kissei Pharmaceutical Co Ltd

-- Kyorin Pharmaceutical Co Ltd

-- Merck & Co

-- Merck KGaA

-- Merckle GmbH

-- Mitsubishi Pharma Corporation

-- Novartis

-- Novo Nordisk

-- Ono Pharmaceutical

-- Protez Pharmaceuticals Inc

-- Regeneron Pharmaceuticals Inc

-- sanofi-aventis

-- Schering-Plough

-- Sunesis Pharmaceuticals Inc

-- Taisho Pharmaceutical Co Ltd

For more information visit http://www.researchandmarkets.com/reports/c37571

Source: Business Wire

More News in this Category